Literature DB >> 4064375

Cholera antibody production in vitro by peripheral blood lymphocytes following oral immunization of humans and mice.

N Lycke, L Lindholm, J Holmgren.   

Abstract

We have studied specific antibody production from peripheral blood lymphocytes (PBL) after oral cholera immunization of humans and mice. Two oral immunizations with cholera toxin (CT) in mice or a single dose of the combined cholera B-subunit/whole cell vaccine in humans gave rise to PBL which spontaneously secreted cholera-specific antibodies when cultured in vitro. A high proportion of IgA antibodies was seen in contrast to antibodies produced by PBL after parenteral immunization which were predominantly IgG. Cultured PBL produced antitoxin as well as anti-lipopolysaccharide antibodies after oral immunization, whereas serum only revealed titre rises for anti-CT. Antibody-secreting PBL appeared in the blood 2-4 days after immunization and persisted for about two weeks with a peak after 6-8 days. Mitogen stimulation in vitro of PBL from multiply-orally vaccinated humans activated a population of specific IgM antibody-secreting cells which persisted for several months following immunization, suggesting the presence of long-lived memory cells. The analysis of IgA antibody production from in-vitro cultured PBL seems to be a promising technique to assess the local immunogenicity of oral vaccines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064375      PMCID: PMC1577414     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Differential synthesis of IgM and IgA anti-tetanus toxoid antibody in vitro following in vivo booster immunization of humans.

Authors:  R H Stevens; A Saxon
Journal:  Cell Immunol       Date:  1979-06       Impact factor: 4.868

2.  Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine.

Authors:  R A Cash; S I Music; J P Libonati; J P Craig; N F Pierce; R B Hornick
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization.

Authors:  R H Stevens; E Macy; C Morrow; A Saxon
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

5.  Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats.

Authors:  N F Pierce; W C Cray
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

6.  Antibody synthesis in vitro, a marker of B cell differentiation.

Authors:  J Kettman; M Wetzel
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

Authors:  A M Svennerholm; M Jertborn; L Gothefors; A M Karim; D A Sack; J Holmgren
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

8.  Detection of plaque-forming cells in the peripheral blood of actively immunized humans.

Authors:  P D Thomson; N S Harris
Journal:  J Immunol       Date:  1977-04       Impact factor: 5.422

9.  Protective antitoxic cholera immunity in mice: influence of route and number of immunizations and mode of action of protective antibodies.

Authors:  S Lange; J Holmgren
Journal:  Acta Pathol Microbiol Scand C       Date:  1978-08

10.  In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus.

Authors:  R Yarchoan; B R Murphy; W Strober; M L Clements; D L Nelson
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

View more
  15 in total

1.  Host defense against cholera toxin is strongly CD4+ T cell dependent.

Authors:  E Hörnqvist; T J Goldschmidt; R Holmdahl; N Lycke
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

2.  Cholera toxin adjuvant promotes long-term immunological memory in the gut mucosa to unrelated immunogens after oral immunization.

Authors:  M Vajdy; N Y Lycke
Journal:  Immunology       Date:  1992-03       Impact factor: 7.397

3.  Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Authors:  C Czerkinsky; A M Svennerholm; M Quiding; R Jonsson; J Holmgren
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

4.  Adoptive transfer of gut mucosal antitoxin memory by isolated B cells 1 year after oral immunization with cholera toxin.

Authors:  N Lycke; J Holmgren
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

5.  Enumeration of Gut-Homing β7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique.

Authors:  Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Naoshin Sharmin Nishat; Deena Al Mahbuba; Rasheduzzaman Rashu; Kamrul Islam; Lazina Hossain; Ayan Dey; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ann-Mari Svennerholm; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2015-10-28

6.  Spontaneous Ig secretion and DNA synthesis in lymphoblastoid B cells appearing after surgery.

Authors:  F Di Padova; M Dürig
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

Review 7.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

Review 8.  Enteric immunization reveals a T cell network for IgA responses and suggests that humans possess a common mucosal immune system.

Authors:  J R McGhee; H Kiyono; S M Michalek; J Mestecky
Journal:  Antonie Van Leeuwenhoek       Date:  1987       Impact factor: 2.271

9.  Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant.

Authors:  R J Jackson; K Fujihashi; J Xu-Amano; H Kiyono; C O Elson; J R McGhee
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  Deficient induction of the immune response to oral immunization with cholera toxin in malnourished rats during suckling.

Authors:  J Fló; M E Roux; E Massouh
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.